Clinical Trials
All Clinical Trials - Page 73 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00293670Phase 4Unknown
FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer
Gonadorelin
- NCT00003124Phase 2Completed
Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
Gonadorelin
- NCT00002889Phase 2Completed
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
Gonadorelin
- NCT00002967Phase 3Completed
Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
Octreotide
- NCT00262470Phase 1/Phase 2Active Not Recruiting
Treatment of Orthostatic Intolerance
Octreotide
- NCT00003057Phase 3Completed
Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
Octreotide
- NCT00616408N/ACompleted
Prediction of Tumor Shrinkage in Acromegaly
Octreotide
- NCT00703079N/ACompleted
Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly
Octreotide
- NCT00615004N/ACompleted
Cardiovascular Outcome After Surgery or Somatostatin Analogues
Octreotide
- NCT00002947Phase 1Terminated
Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer
Octreotide
- NCT00002864Phase 3Completed
Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
Octreotide
- NCT00670501Phase 3Completed
Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
Teriparatide
- NCT00000380N/ACompleted
Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances
Sermorelin
- NCT00008073Phase 1Completed
Octreotide and Doxorubicin in Treating Patients With Advanced Cancer
Octreotide
- NCT00004363N/ACompleted
Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus
Desmopressin
- NCT00004364N/AUnknown
Study of Novel Types of Familial Diabetes Insipidus
Desmopressin
- NCT00116220Phase 3Completed
Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer
Gonadorelin
- NCT00002651Phase 3Completed
SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer
Gonadorelin
- NCT00002633Phase 3Completed
Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
Gonadorelin
- NCT00004327Phase 2Completed
Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia
Octreotide
- NCT00461149Phase 4Completed
Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly
Octreotide
- NCT00227253N/ARecruiting
Chromosome 18 Clinical Research Center
Gonadorelin
- NCT00002582Phase 3Completed
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
Gonadorelin
- NCT00002580Phase 3Completed
Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer
Gonadorelin
- NCT00004332N/ACompleted
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
Sermorelin
- NCT00004771Phase 2Completed
Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease
Gonadorelin
- NCT00001259Phase 1Completed
A Treatment Study for Premenstrual Syndrome (PMS)
Gonadorelin
- NCT00660010Phase 3Completed
Study of Lupron Depot In The Treatment of Central Precocious Puberty
Gonadorelin
- NCT00383656Phase 2Unknown
Pulsatile GnRH in Anovulatory Infertility
Gonadorelin
- NCT00001228Phase 2Completed
Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer
Octreotide
- NCT00002460Phase 3Unknown
Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
Gonadorelin
- NCT00005006Phase 2Completed
Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
Teriparatide
- NCT00004330N/ACompleted
Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks
Gonadorelin
- NCT07629401N/AAvailable
Pre-approval Expanded Access of Retatrutide (LY3437943)
Retatrutide
- NCT06863363Phase 4Not Yet Recruiting
PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults
Semaglutide
- NCT00001036Phase 1Completed
The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection
Thymosin-Alpha-1
- NCT00082082Phase 2Completed
A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma
Thymosin-Alpha-1
- NCT04689360N/AAvailable
An Intermediate Size Expanded Access Protocol of Elamipretide
Elamipretide
- NCT01533532Phase 2Completed
A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)
Gonadorelin
- NCT01629420Phase 2Completed
A Phase II Randomized Open Label Study of KLH-2109 in Patients With Endometriosis
Gonadorelin
- NCT00505817Phase 4Completed
GnRH Agonist and Antagonists in an Oocyte Donation Program
Gonadorelin
- NCT00888082Phase 3Withdrawn
Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy
Gonadorelin
- NCT00767286Phase 3Completed
Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
Gonadorelin
- NCT02065323Phase 2Withdrawn
A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT
Gonadorelin
- NCT00669786Phase 3Completed
Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles
Gonadorelin
- NCT05183802N/AApproved For Marketing
An Expanded Access Protocol for Setmelanotide for Treatment of Bardet-Biedl Syndrome (BBS)
Setmelanotide
- NCT02223416Phase 1Completed
A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo
Teriparatide
- NCT00046137Phase 3Completed
Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis
Teriparatide
- NCT02217826Phase 1Completed
Single Dose Pharmacodynamic and Pharmacokinetic Study of DG3173
Octreotide
- NCT00002252N/ACompleted
A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea
Octreotide